天润工业技术股份有限公司 天润工业技术股份有限公司（以下简称"公司"）第六届董事会独立 董事专门会议第三次会议于2025年8月15日召开，本次会议已于2025年8月 立董事曲国霞女士担任本次会议的召集人并主持本次会议，会议应出席独 立董事3人，实际出席独立董事3人。本次会议的召开和表决程序符合《上 市公司独立董事管理办法》和公司《独立董事工作制度》等规定。经各位 独立董事审议，会议形成如下决议： 一、会议以3票同意、0票反对、0票弃权，审议通过了《关于增加2025 年度日常关联交易预计额度的议案》。 经核查，我们认为：公司本次增加2025年度日常关联交易预计金额符 合公司实际生产经营的需要，关联交易价格参照市场价格确定，定价公允 合理，不存在违反公开、公平、公正原则的情况，不影响公司运营的独立 性，不存在损害公司和股东尤其是中小股东利益的情形，符合公司整体利 益。 我们对该事项表示同意，并同意将该议案提交公司董事会审议。 独立董事：曲国霞、孟红、姚春德 — 1 — ...

Core Viewpoint - Xiamen Tungsten Co., Ltd. is entering into a daily related transaction framework agreement with a newly added related party, Fujian Industrial Holding Group Co., Ltd., following a change in its indirect controlling shareholder [1][2][7]. Summary by Sections Daily Related Transactions Overview - The agreement aims to regulate the related transactions between Xiamen Tungsten and Fujian Industrial Holding Group, establishing pricing principles and transaction types for a period of three years [2][5]. Related Party and Relationship Introduction - Fujian Rare Earth Group holds 28.38% of Xiamen Tungsten's shares, making it the direct controlling shareholder. Fujian Industrial Holding Group indirectly controls Xiamen Tungsten through its ownership of Fujian Metallurgy [2][3]. Financial and Operational Capacity - Fujian Industrial Holding Group is a legally established enterprise with a total asset value of 16,077,751.49 million yuan as of June 30, 2025, indicating a stable financial and operational capacity [4]. Main Content and Pricing Policy of the Agreement - The agreement covers various types of transactions, including the supply of raw materials and services. The total transaction amount will be estimated annually and submitted for board or shareholder approval [5][6]. Purpose and Impact of Related Transactions - The transactions are intended to meet the operational needs of the company, enhance resource allocation, and improve production efficiency without adversely affecting the company's financial status or independence [5][6]. Special Review Opinions - Independent directors and the audit committee have reviewed and approved the agreement, confirming that it adheres to fair pricing principles and does not harm the interests of the company or its shareholders [6][7].

Group 1 - The company has approved the addition of new related parties and adjustments to the expected daily related transactions for 2025, which will be submitted to the shareholders' meeting for review [1][2][3] - The adjustment is due to the transfer of 80% equity of Fujian Metallurgy (Holding) Co., Ltd. from the Fujian Provincial Government to Fujian Industrial Holding Group Co., Ltd., making the latter an indirect controlling shareholder [2][3] - The expected amount of daily related transactions for 2025 has increased by 42,010,000 RMB, bringing the total to 264,075,000 RMB [2][3][6] Group 2 - The company anticipates an increase in procurement and sales transactions with Fujian Industrial Holding Group and its subsidiaries, with an expected increase of 42,000,000 RMB for procurement and 10,000 RMB for labor services [2][3][4] - The company has established a framework agreement for daily related transactions with several related parties, including Fujian Metallurgy and Zhongtung High-tech, to ensure compliance with pricing policies [23][6] - The financial and credit status of the related parties is generally good, indicating a strong ability to fulfill obligations related to these transactions [23]

Core Viewpoint - The company reported a decline in profits due to increased depreciation and financial costs from its subsidiaries, intensified competition in the industry, and a reduction in government subsidies compared to the previous year [1][2][3]. Financial Data - The company experienced a profit decline primarily due to: 1. Increased depreciation and financial costs from Jiangxi Hongtai Logistics Co., Ltd. after project acceptance [1]. 2. Decreased performance of Jiangxi Yongning Technology Co., Ltd. due to intensified competition in the potassium perchlorate production industry [1]. 3. A reduction in government subsidies, with the current year's subsidies being 10 million yuan less than the previous year [1]. Shareholder Information - The company has not reported any changes in the controlling shareholder or actual controller [2]. Daily Related Transactions - The company approved a proposal for expected daily related transactions for 2025 without requiring shareholder meeting approval, ensuring these transactions do not affect the company's independence or operational capabilities [4][5][6]. Audit Firm Appointment - The company proposed to reappoint Da Xin Accounting Firm for the 2025 financial audit, highlighting the firm's extensive experience and commitment to independent and objective auditing practices [16][17][28].

Group 1 - The company plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares, totaling 364,598,146.20 yuan (including tax) [2][15][17] - The profit distribution plan is based on the total share capital as of the equity distribution registration date, with adjustments if the total share capital changes before that date [15][17][18] - The profit distribution proposal requires approval from the company's sixth extraordinary general meeting in 2025 [18][22] Group 2 - The company has approved an increase in daily related transactions for 2025, which are necessary for its ongoing operations and will not adversely affect the company's independence [5][12][38] - The independent directors have confirmed that the decision-making process for the related transactions complies with legal regulations and does not harm the interests of minority shareholders [6][12][38] - The company held a board meeting on August 18, 2025, where all directors participated and unanimously approved the related transaction proposal [37][41] Group 3 - The company will hold a performance briefing on August 26, 2025, to discuss its half-year results and financial indicators with investors [28][29][30] - Investors can participate in the briefing through the Shanghai Stock Exchange's online platform and submit questions in advance [31][32][33] - Key company executives, including the chairman and general manager, will be present to address investor inquiries during the briefing [30][31]

Group 1 - The company held its 25th meeting of the second board on August 18, 2025, with all 7 directors present, confirming compliance with legal and regulatory requirements [1] - The board approved the 2025 semi-annual report, affirming that it accurately reflects the company's financial status and operational results without any misleading statements or omissions [2][3] - The board also approved the special report on the storage and actual use of raised funds, confirming compliance with relevant laws and regulations [2][3] Group 2 - The board approved the expected daily related transactions for 2025, stating that the decision-making process is legal and does not harm the interests of the company or its shareholders [3] - The board authorized the opening of special accounts for raised funds to enhance the efficiency of fund usage and maintain investor rights, with all 7 votes in favor [4]

Core Viewpoint - The announcement details the expected daily related transactions for the year 2025 by Hangzhou Rewei Electric Heating Technology Co., Ltd, emphasizing that these transactions are necessary for normal business operations and will not affect the company's independence or create dependency on related parties [1][2]. Summary of Related Transactions - The board of directors approved the expected daily related transactions for 2025 without requiring a shareholders' meeting, with independent director Hu Chunrong abstaining from the vote [1][2]. - The independent directors confirmed that the expected transactions align with the company's operational needs and that the decision-making process is legal and effective, ensuring fair pricing and settlement [2]. - The expected amount for related transactions in 2025 is set at 18 million yuan, which constitutes 1.80% of the total expected procurement of raw materials for the year [2]. Previous Related Transactions - The previous year's expected related transactions and actual execution were reviewed, with a notable transaction involving the purchase of raw materials from Zhejiang Wanliyang New Materials Co., Ltd [2]. - The actual amount for 2024 was 5.69 million yuan, with no significant discrepancies reported [2]. Related Parties and Relationships - Zhejiang Wanliyang New Materials Co., Ltd is a wholly-owned subsidiary of Zhejiang Wanliyang Co., Ltd, with independent director Hu Chunrong serving on its board, establishing a clear related party relationship [3][4]. - The company has confirmed that Zhejiang Wanliyang New Materials Co., Ltd has a good credit standing and is capable of fulfilling its obligations [4]. Transaction Details and Pricing Policy - The expected related transactions primarily involve the procurement of raw materials necessary for the company's operations [5]. - The pricing for these transactions will be based on market prices and industry practices, ensuring fairness and preventing harm to the interests of the company and its shareholders [5]. Purpose and Impact of Related Transactions - The expected related transactions are deemed essential for the company's operational and business development needs, adhering to principles of fairness and reasonableness [5]. - The transactions will not compromise the company's independence, and the main business operations will not become reliant on related parties [5]. Verification by Sponsoring Institution - The sponsoring institution has verified that the related transactions have been properly reviewed and approved by the board and supervisory committee, with independent directors having conducted a special meeting to discuss the transactions [5].

Core Viewpoint - The report outlines the expected daily related transactions of Hangzhou Rewei Electric Heating Technology Co., Ltd. for the year 2025, emphasizing compliance with relevant regulations and the necessity of these transactions for the company's operations [1][4]. Group 1: Daily Related Transactions Overview - The expected daily related transactions for 2025 primarily involve the purchase of raw materials from Zhejiang Wanliyang New Materials Co., Ltd., which is a wholly-owned subsidiary of Zhejiang Wanliyang Co., Ltd. [2][3]. - The estimated amount for purchasing raw materials from the related party is 18 million yuan, accounting for 1.80% of the total expected procurement for the year [1][3]. Group 2: Related Party Introduction and Relationship - Zhejiang Wanliyang New Materials Co., Ltd. is involved in various activities including the manufacturing and sales of non-ferrous metal alloys, recycling of resources, and technical services [2]. - The independent director of the company, Hu Chunrong, serves as a director at Zhejiang Wanliyang Co., Ltd., establishing a related party relationship [3]. Group 3: Transaction Purpose and Impact - The expected daily related transactions are deemed necessary for the company's normal production and operational needs, ensuring that the transactions adhere to fair and reasonable pricing principles [3][4]. - The company asserts that these transactions will not affect its independence and will not create dependency on the related party [3]. Group 4: Review Procedures for Related Transactions - The board of directors has approved the expected daily related transactions for 2025, with the independent director recusing himself from the vote [4]. - The independent directors conducted a special meeting to review the transactions, confirming that the decision-making process was legal and effective [4]. Group 5: Sponsor Institution's Verification Opinion - The sponsor institution, Guotai Junan Securities Co., Ltd., has verified that the related transactions comply with legal procedures and do not harm the interests of the company or its shareholders [4].

Core Viewpoint - The announcement details the establishment of new related party relationships and the expected daily related transactions for the year 2025, emphasizing that these transactions will not harm the interests of the company or minority shareholders and will adhere to fair market pricing principles [1][8]. Group 1: Daily Related Transactions Overview - The company is undergoing a pre-restructuring process initiated by the local court, which has appointed a temporary management team to oversee the restructuring efforts [1][2]. - The expected total amount for daily related transactions in 2025 is projected to be no more than RMB 110 million, involving "technical consulting services" and "beneficial debt borrowing" [2][3]. - The board of directors has approved the proposal for these related transactions, with a voting outcome of 6 in favor and no opposition [2][3]. Group 2: Related Parties and Relationships - Hunan Chuantou Industrial Development Co., Ltd. is identified as a new related party, which will gain actual control of the company post-restructuring [2][5]. - Hunan Chuantou has no prior relationships with the company or its management before the signing of the pre-restructuring investment agreement [5][7]. - Hunan New Harmony Biological Medicine Co., Ltd. is also noted as a related party, with similar conditions regarding prior relationships [6][7]. Group 3: Transaction Details and Pricing - The related transactions include borrowing beneficial debt and signing technical consulting service agreements, which are necessary for normal business operations [7][8]. - Pricing for these transactions will be determined based on fair market principles, ensuring that they do not harm the interests of the company or its shareholders [8][9]. Group 4: Impact on Company Operations - The related transactions are deemed essential for the company's daily operations and are expected to positively influence its business activities [8]. - The company maintains independence from related parties in various aspects, ensuring that these transactions do not lead to dependency or control by the related parties [8][9].

证券代码：300765 证券简称：新诺威 公告编号： 2025-064 石药创新制药股份有限公司 关于增加 2025 年度日常关联交易预计额度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 日常关联交易基本情况 （一）日常关联交易概述 开的第六届董事会第二十一次会议、2025 年 1 月 8 日召开的 2025 年第一次临时 股东大会审议通过了《关于公司 2025 年度日常关联交易预计额度的议案》，对 月 20 日披露的《关于公司 2025 年度日常关联交易预计额度公告》（公告编号： 过《关于增加公司 2025 年度日常关联交易预计额度的议案》，综合考虑公司后 续业务 情况 ，公 司决 定增加 与关 联方 Conjupro Biotherapeutics Inc. 、CSPC IBERICA S.L.、CSPC Dermay Europe GMBH、河北华荣制药有限公司日常关联 交易预计额度。 该议案经公司独立董事专门会议审议通过后提交公司董事会审议，关联董事 姚兵、CAI LEI、韩峰、徐雯已对此议案回避表决。根据《深圳证券交易所创业 板股票上 ...